![Extrinsic Evidence Needed to Construe Numerical Limitation in the Claims | IP Law Firm | Harness IP Extrinsic-Evidence_Harness-IP_Intellectual-Property-Law-Firm](https://www.harnessip.com/wordpress/wp-content/uploads/2024/01/Extrinsic-Evidence_Harness-IP_Intellectual-Property-Law-Firm-330x165.jpg)
![Extrinsic Evidence Needed to Construe Numerical Limitation in the Claims | IP Law Firm | Harness IP Extrinsic-Evidence_Harness-IP_Intellectual-Property-Law-Firm](https://www.harnessip.com/wordpress/wp-content/uploads/2024/01/Extrinsic-Evidence_Harness-IP_Intellectual-Property-Law-Firm-330x165.jpg)
![WIPO Standard ST.26 Tips as of 16 August 2022 | IP Law Firm | Harness IP WIPO Standard ST.26 Tips_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP](https://www.harnessip.com/wordpress/wp-content/uploads/2022/10/Big-Bang-Blog-Series_Image-6-330x174.jpg)
October 5, 2022
WIPO Standard ST.26 Tips as of 16 August 2022
![WIPO ST.26 Resources | IP Law Firm | Harness IP WIPO resources_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP](https://www.harnessip.com/wordpress/wp-content/uploads/2022/09/Big-Bang-Blog-Series_Image-5-330x174.jpg)
September 28, 2022
WIPO ST.26 Resources
![Features of WIPO Sequence | IP Law Firm | Harness IP WIPO sequence features_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP_](https://www.harnessip.com/wordpress/wp-content/uploads/2022/09/Big-Bang-Blog-Series_Image-4-330x174.jpg)
September 21, 2022
Features of WIPO Sequence
![ST.25 vs. ST.26 Sequence Listings | IP Law Firm | Harness IP WIPO ST.25 vs ST.26_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP_](https://www.harnessip.com/wordpress/wp-content/uploads/2022/09/Big-Bang-Blog-Series_Image-3-330x174.jpg)
September 13, 2022
ST.25 vs. ST.26 Sequence Listings
![WIPO ST.26 Overview | IP Law Firm | Harness IP WIPO ST.26_Big Bang Blog Series_Intellectual Property Law Firm | Harness IP_](https://www.harnessip.com/wordpress/wp-content/uploads/2022/09/Big-Bang-Blog-Series_Image-2-330x174.jpg)
September 7, 2022
WIPO ST.26 Overview
![The Big Bang Blog Series - The New WIPO Standard | IP Law Firm | Harness IP Harness IP_Intellectual Property_The Big Bang Blog Series_WIPO .26 Standards](https://www.harnessip.com/wordpress/wp-content/uploads/2022/08/Big-Bang-Blog-Series_Image-1-01-330x174.jpg)
August 30, 2022
The Big Bang Blog Series – The New WIPO Standard
![FDA Publishes New Guidance Limiting Petitions that Could Delay Biosimilar Applications | IP Law Firm | Harness IP FDA Guidance Biosimilars Patent Prosecution | Intellectual Property Law Firm | Harness IP](https://www.harnessip.com/wordpress/wp-content/uploads/2019/09/FDA-Guidance-Biosimilars-Patent-Prosecution-330x135.jpg)
![Abandoning Infringing Conduct Caused Loss of Standing to Appeal IPR | IP Law Firm | Harness IP photo of biosimilar medications](https://www.harnessip.com/wordpress/wp-content/uploads/2018/08/pexels-photo-860378-330x220.jpeg)
February 7, 2019
Abandoning Infringing Conduct Caused Loss of Standing to Appeal IPR
![Pfizer’s Biosimilar Antitrust Lawsuit Survives Johnson & Johnson’s Motion to Dismiss | IP Law Firm | Harness IP Harness IP Intellectual Property Lawyers](https://www.harnessip.com/wordpress/wp-content/uploads/2015/09/Gavel-1-330x219.jpg)
![FDA Implements Biosimilar Action Plan to Boost Biosimilar Competition | IP Law Firm | Harness IP photo of laboratory and scientist creating biosimilar patents](https://www.harnessip.com/wordpress/wp-content/uploads/2018/08/biosimilar-patent-competition-330x220.jpg)
![At Risk Launch: A Hypothetical Case Study | IP Law Firm | Harness IP image of light bulb to suggest hypothetical biosimilar case study](https://www.harnessip.com/wordpress/wp-content/uploads/2018/08/hypothetical-biosimilar-case-study-330x202.jpeg)
August 9, 2018
At Risk Launch: A Hypothetical Case Study
![Competitor Influence on the Conduct of the Patent Dance and Litigation | IP Law Firm | Harness IP photo of chess pieces representing biosimilar competitive dynamics](https://www.harnessip.com/wordpress/wp-content/uploads/2018/08/biosimilar-competitive-dynamics-e1533754084987-330x185.jpeg)
![Seeking Biosimilar Market Entry When a Competitor is Pursuing Interchangeability: Factors to Consider | IP Law Firm | Harness IP photo of biosimilar medications](https://www.harnessip.com/wordpress/wp-content/uploads/2018/08/pexels-photo-860378-330x220.jpeg)